Stocktoria

Orchestra BioMed Holdings, Inc. OBIO

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-08-04

Orchestra BioMed Holdings, Inc. statistics & valuation

Market cap$253.9M
P / S7.6×
P / B4.7×
Net margin-157.4%
Return on equity-98.4%
FCF margin-147.7%
Net cash$19.7M
Enterprise value USD$234.2M
Earnings yield EBIT/EV-22.1%
Return on capital-52.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-951.30% -1779.70% -2313.30% -157.40% 20212022202320242025
Gross margin (%)
20212022202320242025
Operating margin (%)
-924.30% -1866.20% -2437.50% -154.70% 20212022202320242025
Return on equity (%)
-64.00% -72.20% -185.20% -98.40% 20212022202320242025
Shares outstanding
20.4M 20.2M 35.8M 38.2M 57.0M 20212022202320242025
Net debt ($)
-$7.3M -$19.7M 20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-0.20% -35.20% -51.60% -80.10% -45.90% 20212022202320242025
Free cash flow margin (%)
-845.70% -1674.10% -1927.50% -147.70% 20212022202320242025
Debt / equity (×)
0.46× 0.28× 20212022202320242025
EPS ($)
-$0.02 -$2.24 -$1.48 -$1.66 -$1.11 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Operating margin-154.7%-2437.5%-1866.2%-924.3%—
Net margin-157.4%-2313.3%-1779.7%-951.3%—
FCF margin-147.7%-1927.5%-1674.1%-845.7%—
Return on assets-45.9%-80.1%-51.6%-35.2%-0.2%
Return on equity-98.4%-185.2%-72.2%-64.0%1.9%
Debt / equity0.28×0.46×———
Current ratio6.454.277.954.5610.88

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.